Limit search to available items
Book Cover
Author Evidence for Clinical Utility of Molecular Diagnostics in Oncology (Workshop) (2012 : Washington, D.C.)

Title Genome-based diagnostics : demonstrating clinical utility in oncology : workshop summary / Adam C. Berger and Steve Olson, rapporteurs ; Roundtable on Translating Genomic-Based Research for Health, Board on Health Sciences Policy, Institute of Medicine of the National Academies
Published Washington, D.C. : National Academies Press, 2013


Description 1 online resource (xix, 101 pages) : illustrations
Contents Introduction -- Setting the context -- Perspectives from stakeholders -- Tools for generating and synthesizing evidence -- Advancing molecular diagnostics for oncology
Summary "Genome-Based Diagnostics: Demonstrating Clinical Utility in Oncology is the summary of a workshop convened in May 2012 by the Roundtable on Translating Genomic-Based Research for Health and the Center for Medical Technology Policy of the Institute of Medicine to foster the identified need for further sustained dialogue between stakeholders regarding the clinical utility of molecular diagnostics. The workshop brought together a wide range of stakeholders, including patients, health care providers, policy makers, payers, diagnostic test developers, researchers, and guideline developers, to identify the challenges and opportunities in advancing the development and use of molecular diagnostic tests designed to guide the treatment and management of patients with cancer. The sequencing of the human genome has greatly accelerated the process of linking specific genetic variants with disease. These findings have yielded a rapidly increasing number of molecular diagnostic tests designed to guide disease treatment and management. Many of these tests are aimed at determining the best treatments for specific forms of cancer, making oncology a valuable testing ground for the use of molecular diagnostic tests in medicine in general. Nevertheless, many questions surround the clinical value of molecular diagnostic tests, and their acceptance by clinicians, payers, and patients has been unpredictable. A major limiting factor for the use of these tests has been the lack of clear evidence of clinical utility. Genome-Based Diagnostics assesses the evidentiary requirements for clinical utility of molecular diagnostics used to guide treatment decisions for patients with cancer; discusses methodologies related to demonstrating these evidentiary requirements that meet the needs of all stakeholders; and considers innovative, sustainable research collaborations for generating evidence of clinical utility involving multiple stakeholders"--Publisher's description
Bibliography Includes bibliographical references
Notes Online resource; title from resource home page (National Academies Press, viewed April 23, 2014)
Subject Molecular diagnosis -- Congresses
Cancer -- Molecular diagnosis -- Congresses
Molecular Diagnostic Techniques
Neoplasms -- diagnosis
HEALTH & FITNESS -- Diseases -- General.
MEDICAL -- Clinical Medicine.
MEDICAL -- Diseases.
MEDICAL -- Evidence-Based Medicine.
MEDICAL -- Internal Medicine.
Cancer -- Molecular diagnosis
Molecular diagnosis
Genre/Form proceedings (reports)
Conference papers and proceedings
Conference papers and proceedings.
Actes de congrès.
Form Electronic book
Author Berger, Adam C., rapporteur.
Olson, Steve, 1956- rapporteur
Institute of Medicine (U.S.). Roundtable on Translating Genomic-Based Research for Health, issuing body.
ISBN 9780309269605